Skip to main content

Table 1 Genes altered by CNA with a frequency significantly different in ER+ and ER- ERBB2-amplified tumors.

From: Genome profiling of ERBB2-amplified breast cancers

ER status of ERBB2-amplified tumors

Targeted by gene CNA

Altered genes

Location

CNV, Type#

ER-

gain

GDPD4

11q13.5

 
  

PAK1

  
  

CLNS1A

  

ER+

gain

ADAM5P

8p11.23

Variation_1197, CNV

  

ADAM3A

 

Variation_1779, CNV

  

TRPS1*

8q23.3

Variation_42116, InDel

  

BC040336

  
  

EIF3H

  
  

AL713790

8q24.11

 
  

SLC30A8

  
  

MED30

  
  

SAMD12

8q24.12

Variation_3145, CNV

  

FAM91A1

8q24.13

 
  

C8orf54

  
  

C8orf78

  
  

BC015129

  
  

TMEM65

 

Variation_52365, CNV

  

CR933665

  
  

RNF139

 

Variation_28765, InDel

  

TATDN1

  
  

MTSS1

 

Variation_43549, CNV

  

LOC157381

  
  

SQLE

 

Variation_34021, InDel

  

KIAA0196

  
  

NSMCE2

 

Variation_41128, Indel

  

TRIB1

  
  

BC038572

8q24.21

 
  

FAM84B

 

Variation_37296, Inversion

  

PVT1*

 

Variation_8615, CNV

  

BC009730

  
 

amplification

C8ORFK23

8q24.13

 
  

LOC650095

  
  

LOC90110

17q12

Variation_5006, CNV

  

FBXL20

 

CNVVariation_5006, CNV

  

CASC3

17q21.1

 
 

gain or amplification

ZNF572

8q24.13

 
  

AK093407

  
 

loss or deletion

SAMD11

1p36.33

Variation_30362, CNV

  

AGRN

 

Variation_2294, CNV

  

GNB1

 

Variation_3276, CNV

  

AK128532

1p36.32

 
  

RNF212

4p16.3

Variation_30190, CNV

  

B4GALNT4

11p15.5

Variation_29880, CNV

  1. *TRPS1 and PVT1 gene expression was in proportion to their CNA
  2. #The information about the presence of CNV and the type of genomic variations (CNV, InDel, inversion...) was extracted from hg17 and hg18.